Maturana-Ramírez A, Aitken-Saavedra J, Guevara-Benítez AL, Espinoza-Santander I. Hypovitaminosis D, oral potentially malignant disorders, and oral squamous cell carcinoma: a systematic review. Med Oral Patol Oral Cir Bucal. 2022 Mar 1;27 (2):e135-41.
doi:10.4317/medoral.25049
https://dx.doi.org/doi:10.4317/medoral.25049
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424. |
PMid:30207593 |
2. Seoane-Romero JM, Vázquez-Mahía I, Seoane J, Varela-Centelles P, Tomás I, López-Cedrún JL. Factors related to late-stage diagnosis of oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal. 2012;17:e35-40. |
PMid:21743390 PMCid:PMC3448190 |
3. Gupta S, Kong W, Peng Y, Miao Q, Mackillop WJ. Temporal trends in the incidence and survival of cancers of the upper aerodigestive tract in Ontario and the United States. Int J Cancer. 2009;125:2159-65. |
PMid:19569190 |
4. El-Naggar AK, Chan JKC, Takata T, Grandis JR, Slootweg PJ. The fourth edition of the head and neck World Health Organization blue book: editors' perspectives. Hum Pathol. 2017;66:10-2. |
PMid:28583885 |
5. Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:612-27. |
PMid:29396319 |
6. Warnakulasuriya S. Oral potentially malignant disorders: A comprehensive review on clinical aspects and management. Oral Oncol. 2020;102:104550. |
PMid:31981993 |
7. Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014;14:342-57. |
PMid:24705652 |
8. Lips P. Vitamin D physiology. Prog Biophys Mol Biol. 2006;92:4-8. |
PMid:16563471 |
9. Krishnan AV, Feldman D. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol. 2011;51:311-36. |
PMid:20936945 |
10. Fanidi A, Muller DC, Midttun Ø, Ueland PM, Vollset SE, Relton C, et al. Circulating vitamin D in relation to cancer incidence and survival of the head and neck and oesophagus in the EPIC cohort. Sci Rep. 2016;6:36017. |
PMid:27812016 PMCid:PMC5095706 |
11. Udeabor SE, Albejadi AM, Al-Shehri WAK, Onwuka CI, Al-Fathani SY, Al Nazeh AA, et al. Serum levels of 25-hydroxy-vitamin D in patients with oral squamous cell carcinoma: Making a case for chemoprevention. Clin Exp Dent Res. 2020;6:428-32. |
PMid:32246747 PMCid:PMC7453769 |
12. Bahramian A, Bahramian M, Mehdipour M, Falsafi P, Khodadadi S, Dabaghi Tabriz F, et al. Comparing Vitamin D Serum Levels in Patients with Oral Lichen Planus and Healthy Subjects. J Dent (Shiraz). 2018;19:212-6. |
PMid:30175191 |
13. Bochen F, Balensiefer B, Körner S, Bittenbring JT, Neumann F, Koch A, et al. Vitamin D deficiency in head and neck cancer patients - prevalence, prognostic value and impact on immune function. Oncoimmunology. 2018;7:e1476817. |
PMid:30228945 PMCid:PMC6140588 |
14. Anand A, Singh S, Sonkar AA, Husain N, Singh KR, Singh S, et al. Expression of vitamin D receptor and vitamin D status in patients with oral neoplasms and effect of vitamin D supplementation on quality of life in advanced cancer treatment. Contemp Oncol (Pozn). 2017;21:145-51. |
PMid:28947884 PMCid:PMC5611504 |
15. Grimm M, Cetindis M, Biegner T, Lehman M, Munz A, Teriete P, et al. Serum vitamin D levels of patients with oral squamous cell carcinoma (OSCC) and expression of vitamin D receptor in oral precancerous lesions and OSCC. Med Oral Patol Oral Cir Bucal. 2015;20:e188-95. |
PMid:25662556 PMCid:PMC4393981 |
16. Young MR, Levingston C, Johnson SD. Cytokine and Adipokine Levels in Patients with Premalignant Oral Lesions or in Patients with Oral Cancer Who Did or Did Not Receive 1α,25-Dihydroxyvitamin D3 Treatment upon Cancer Diagnosis. Cancers (Basel). 2015;25:1109-24. |
PMid:26120967 PMCid:PMC4586760 |
17. Zhang H, Lu H, Shrestha C, Feng Y, Li Y, Peng J, et al. In serum, higher parathyroid hormone but not lower vitamin D is associated with oral squamous cell carcinoma. Curr Oncol. 2015;22:e259-63. |
PMid:26300676 PMCid:PMC4530823 |
18. Orell-Kotikangas H, Schwab U, Österlund P, Saarilahti K, Mäkitie O, Mäkitie AA. High prevalence of vitamin D insufficiency in patients with head and neck cancer at diagnosis. Head Neck. 2012;34:1450-5. |
PMid:22287291 |
19. Walker DD, Reeves TD, de Costa AM, Schuyler C, Young MR. Immunological modulation by 1α,25-dihydroxyvitamin D3 in patients with squamous cell carcinoma of the head and neck. Cytokine. 2012;58:448-54. |
PMid:22450225 PMCid:PMC3340440 |
20. Walsh JE, Clark AM, Day TA, Gillespie MB, Young MR. Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma. Hum Immunol. 2010l;71:659-65. |
PMid:20438786 PMCid:PMC3337687 |
21. Lipworth L, Rossi M, McLaughlin JK, Negri E, Talamini R, Levi F, et al. Dietary vitamin D and cancers of the oral cavity and esophagus. Ann Oncol. 2009;20:1576-81. |
PMid:19487490 |
22. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;15:1941-53. |
PMid:30350310 |
23. Balsaraf S, Bhambal A, Chole R. Study of oral potentially malignant disorders related to various risk factors amongst the patients' attending hospitals in Bhopal, India. Med Pharm Rep. 2019;92:66-71. |
PMid:30957089 PMCid:PMC6448500 |
24. Ellington TD, Henley SJ, Senkomago V, O'Neil ME, Wilson RJ, Singh S, et al. Trends in Incidence of Cancers of the Oral Cavity and Pharynx - United States 2007-2016. MMWR Morb Mortal Wkly Rep. 2020;69:433-8. |
PMid:32298244 PMCid:PMC7755056 |
25. Montero PH, Patel SG. Cancer of the oral cavity. Surg Oncol Clin N Am. 2015;24:491-508. |
PMid:25979396 PMCid:PMC5018209 |
26. Varghese SS, George GB, Sarojini SB, Vinod S, Mathew P, Mathew DG, et al. Epidemiology of Oral Lichen Planus in a Cohort of South Indian Population: A Retrospective Study. J Cancer Prev. 2016;21:55-9. |
PMid:27051650 PMCid:PMC4819667 |
27. Pires FR, Ramos AB, Oliveira JB, Tavares AS, Luz PS, Santos TC. Oral squamous cell carcinoma: clinicopathological features from 346 cases from a single oral pathology service during an 8-year period. J Appl Oral Sci. 2013;21:460-7. |
PMid:24212993 PMCid:PMC3881836 |
28. Mousavi SE, Amini H, Heydarpour P, Amini Chermahini F, Godderis L. Air pollution, environmental chemicals, and smoking may trigger vitamin D deficiency: Evidence and potential mechanisms. Environ Int. 2019;122:67-90. |
PMid:30509511 |
29. Wimalawansa SJ, Razzaque MS, Al-Daghri NM. Calcium and vitamin D in human health: ¿Hype or real?. J Steroid Biochem Mol Biol. 2018;180:4-14. |
PMid:29258769 |
30. Płudowski P, Karczmarewicz E, Bayer M, Carter G, Chlebna-Sokół D, Czech-Kowalska J, et al. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe - recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol. 2013;64:319-27. |
PMid:24002961 |
31. Spiro A, Buttriss JL. Vitamin D: An overview of vitamin D status and intake in Europe. Nutr Bull. 2014;39:322-50. |
PMid:25635171 PMCid:PMC4288313 |
32. Vitamin D. Monograph. Altern Med Rev. 2008;13:153-64. |
PMid:18590351 |
33. Pludowski P, Holick MF, Grant WB, Konstantynowicz J, Mascarenhas MR, Haq A, et al. Vitamin D supplementation guidelines. J Steroid Biochem Mol Biol. 2018;175:125-35. |
PMid:28216084 |
34. Verma A, Vincent-Chong VK, DeJong H, Hershberger PA, Seshadri M. Impact of dietary vitamin D on initiation and progression of oral cancer. J Steroid Biochem Mol Biol. 2020;199:105603. |
PMid:31981799 PMCid:PMC7166186 |
35. Haines ST, Park SK. Vitamin D supplementation: what's known, what to do, and what's needed. Pharmacotherapy. 2012;32:354-82. |
PMid:22461123 |
36. Małodobra-Mazur M, Paduch A, Lebioda A, Konopacka M, Rogoliński J, Szymczyk C, et al. VDR gene single nucleotide polymorphisms and their association with risk of oral cavity carcinoma. Acta Biochim Pol. 2012;59:627-30. |
PMid:23189278 |
37. Laczmanski L, Laczmanska I, Lwow F. Association of select vitamin D receptor gene polymorphisms with the risk of tobacco-related cancers - a meta-analysis. Sci Rep. 2019;5:16026. |
PMid:31690771 PMCid:PMC6831593 |
38. Li Q, Li Y, Jiang H, Xiao Z, Wu X, Zhang H, et al. Vitamin D suppressed gastric cancer cell growth through downregulating CD44 expression in vitro and in vivo. Nutr. 2021;15:111413. |
PMid:34450383 |